Dr. Resnick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
593 Eddy St
Department Of Pathology Apc-12
Providence, RI 02903Phone+1 401-444-4380Fax+1 401-444-4377- Is this information wrong?
Education & Training
- Childrens HospitalFellowship, Selective Pathology, 1994 - 1995
- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1990 - 1994
- The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1989
Certifications & Licensure
- MA State Medical License 1993 - 2025
- RI State Medical License 2002 - 2024
- American Board of Pathology Anatomic Pathology
Clinical Trials
- Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- Advancing Artificial Intelligence Integration Into the Pathology Workflow: Exploring Opportunities in Gastrointestinal Tract Biopsies.Fazilet Yilmaz, Arlen Brickman, Fedaa Najdawi, Evgeny Yakirevich, Robert Egger, Murray B Resnick> ;Laboratory Investigation; a Journal of Technical Methods and Pathology. 2024 Feb 29
- Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study.Anstee, Q., Ratziu, V., Rinella, M., Harrison, S., Capozza, T., Sawhney, S., Shelat, N., Sanyal, A., Loomba, R., Kowdley, K., Resnick, M., Younossi, Z.> ;Hepatology Communications. 2024 Jan 1
- Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study.Dacic, S., Travis, W., Giltnane, J., Kos, F., Abel, J., Hilz, S., Fujimoto, J., Sholl, L., Ritter, J., Khalil, F., Liu, Y., Taylor-Weiner, A., Resnick, M., Yu, H., Hir...> ;Journal of Thoracic Oncology. 2023 Dec 7
- Join now to see all
Journal Articles
- In Reply to Dr. Lambein Et Al “HER2 Protein Overexpression in Non‐Amplified Ductal Carcinoma in Situ: Quality Issue or Transcription Mechanisms Gone Awry?”Yiang Hui, Yihong Wang, Murray B Resnick, Histopathology
- Discordant HER2 Immunohistochemical Expression and Gene Amplification in Ductal Carcinoma in Situ ‐ Evaluating HER2 in Synchronous in Situ and Invasive CarcinomaYiang Hui, Shaolei Lu, Murray B Resnick, Yihong Wang, Histopathology
Hospital Affiliations
- Miriam HospitalProvidence, Rhode Island
- Rhode Island HospitalProvidence, Rhode Island
- Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: